| Value | ₹0.81 Cr |
|---|---|
| Execution period | 5 years |
BSE filing, NSE: TRIVENSHET. Summary written from the filing by ALFA Finder's alert engine.
Triveni Glass Ltd: key numbers
- Share price
- ₹9.39
- Market cap
- ₹11.85 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.75 Cr
- P/E (TTM)
- 7.0×Sector 33.1×
- Promoter holding
- 5.82%+0.36% QoQ
- FII holding
- 2.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Triveni Glass Ltd
All →Triveni Glass Q2 FY27 Results: Net Profit ₹2 Cr, Up 900.0% QoQ
Triveni Glass Ltd reported net profit of ₹2 Cr for Q2 FY27.
- Key figure
- Net profit ₹2 Cr
Triveni Glass Board Meeting Date
Triveni Glass will hold a board meeting on October 31, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. This is advance notice of a future meeting, so no results are reported yet.
Triveni Glass Other Announcement
Triveni Glass Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, detailing promoter and public shareholding as per regulatory requirements.
Triveni Glass Promoter Buying: ₹0.01 Cr
Promoter and Director Jitendra Kumar Agrawal acquired 15,000 equity shares of Triveni Glass Limited from the open market for Rs 0.01 Crore.
- Value
- ₹0.01 Cr
- Promoter stake change
- +0.12%
Triveni Glass Promoter Buying: ₹0.11 Cr
Promoter and Director Jitendra Kumar Agrawal bought 15,000 shares of Triveni Glass Ltd for ₹1.12 Lakhs via market purchase.
- Value
- ₹0.11 Cr
- Promoter stake change
- +0.12%
Triveni Glass Other Announcement
Director Finance Anil Kumar Dhawan purchased 20,257 shares of the company from the open market between September 22 and September 30, 2026, totaling ₹0.01 Crore.
- Value
- ₹0.01 Cr
Other business update announcements
All →Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Rajshree Sugars & Chemicals Business Update
Rajshree Sugars reported October 2026 operational data for its three sugar units. Sugar sales were 17,849 MT, with no cane crushed during the month.
Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr